This study analyzed the safety of myomectomy during the cesarean section (CS). Pregnant women who underwent myomectomy during CS in a tertiary center between January 2015 and November 2019 were inc...
1 June 2007 in Acta Obstetricia et Gynecologica Scandinavica
Objective. To evaluate the therapeutic regimens and symptomatic response rates in patients with vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia (mixed disease). Material and methods. Eighty‐three women with biopsy‐proven vulvar mixed disease were evaluated for this retrospective study. All patients were initially treated with topical fluorinated corticosteroids, and then 2% testosterone propionate in petrolatum or 0.05% clobetasol 17‐propionate (44 (53%) versus 39 (47%)). Results. The remission rates were 82 and 93% in the testosterone and clobetasol subgroups at the end of 6 months (p = 0.112), respectively. The disease recurred in 8% of the patients. The recurrence rates in the testosterone and clobetasol arms were 13 and 5%, respectively (p = 0.163). The histopathological review of the repeat vulvar biopsies of the patients without symptomatic relief revealed 6 (60%) patients with persistent disease, 2 (20%) with lichen sclerosus, 1 (10%) with atypical squamous hyperplasia, and 1 (10%) with VIN1. Two patients with recurrent disease and 2 patients with vulvar intraepithelial neoplasia I–II or atypical squamous hyperplasia were treated with skinning vulvectomy. Conclusions. Clobetasol resulted in higher remission and lower recurrence rates than those in testosterone therapy, although statistically significant differences were not obtained. In the evaluation of patients without symptomatic relief, the first step should be a vulvar biopsy to exclude the presence of atypical components.
BACKGROUND Patients undergoing invasive diagnostic and treatment procedures benefit from receiving educational information before the procedure. Amniocentesis can be particularly stressful for the pregnant mother, who may be concerned about the safety of the procedure for herself and the fetus. This study aimed to compare pain and anxiety levels during amniocentesis in 100 women with and without pre-procedural video-based information. MATERIAL AND METHODS The study included 100 pregnant women (50 cases, 50 controls) with a positive screening test for aneuploidy. The State-Trait Anxiety Inventory (STAI) and Visual Analog Scale (VAS) were completed during their initial visit ("Pre-amniocentesis"). The case group watched a 5-minute video about amniocentesis and completed the assessments again ("Post-video"). After the procedure, both groups were reassessed ("Post-amniocentesis"). Results were compared within and between groups. RESULTS Significant differences were found in both STAI-1 and VAS scores between pre- and post-amniocentesis assessments in the case group (P<0.05 for all). However, no significant decrease were observed in the control group. The case group reported less anxiety (38.35 vs 45.25, P: 0.001), pain (16.7 vs 18.5, P: 0.125) and stress (2.18 vs 4.20, P: 0.001) scores after amniocentesis procedure compared to the control group. CONCLUSIONS Video-based education more effectively reduces anxiety and stress levels compared to traditional methods, potentially enhancing patient satisfaction.
10 June 2024 in Journal of Turkish Society of Obstetric and Gynecology
Comparison of metformin, myoinositol and metformin-myoinositol combined treatments for polycystic ovary syndrome - Turkish Journal of Obstetrics and Gynecology